TRex Bio is a stealth mode, discovery-stage biotechnology company focused on making a meaningful difference in the lives of patients suffering from fatal or debilitating illnesses including cancer, fibrotic, autoimmune and inflammatory diseases.
Our translationally driven discovery engine has generated a deep understanding of human immunobiology in healthy and diseased tissues. Through a comprehensive interrogation of human tissue-resident immune cells, we have begun to elucidate the molecular pathways utilized by these cells, with a focus on regulatory T cells (Tregs). Functional manipulation of Tregs in a tissue-specific and disease-specific fashion will result in transformative therapies to treat multiple diseases.
We have raised a substantial Series A to date. Our people are collaborative, data-driven and curious.
Join the team before our big reveal!
0
Total investors
0
Early stage
0
Mid stage
0
Late stage
2018
Founded
Investors
0 investors
All
Early stage
Mid stage
Late stage
No investors in this category
Frequently asked questions
When was TRex Bio founded?
TRex Bio was founded in 2018.
What industry is TRex Bio in?
TRex Bio operates in Biotechnology. Find similar Biotechnology investors on gritt.io.
Where is TRex Bio based?
TRex Bio is headquartered in South San Francisco, United States.
Find investors for your startup like TRex Bio
Gritt sends AI-personalised outreach to each investor — from your Gmail